{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:02:22Z","timestamp":1773662542407,"version":"3.50.1"},"reference-count":47,"publisher":"Japanese Pharmacological Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1254\/jphs.fm0070121","type":"journal-article","created":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T05:51:12Z","timestamp":1201067472000},"page":"15-21","source":"Crossref","is-referenced-by-count":35,"title":["Neuropsychotoxicity of Abused Drugs: Effects of Serotonin Receptor Ligands on Methamphetamine- and Cocaine-Induced Behavioral Sensitization in Mice"],"prefix":"10.1254","volume":"106","author":[{"given":"Yukio","family":"Ago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akemichi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0173(97)00021-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 White FJ, Kalivas PW. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 1998;51:141&ndash;153.","DOI":"10.1016\/S0376-8716(98)00072-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nature Rev Neurosci. 2001;2:119&ndash;128.","DOI":"10.1038\/35053570"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Vanderschuren LJ, Kalivas PW. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology. 2000;151:99&ndash;120.","DOI":"10.1007\/s002130000493"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(02)00965-0"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(92)90493-Y"},{"issue":"15","key":"7","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1021\/jm00041a002","volume":"37","year":"1994","ISSN":"https:\/\/id.crossref.org\/issn\/0022-2623","issn-type":"print"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)02424-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Kuczenski R, Segal DS, Todd PK. Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments. Psychopharmacology. 1997;134:221&ndash;229.","DOI":"10.1007\/s002130050445"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Segal DS, Kuczenski R. In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res. 1992;571:330&ndash;337.","DOI":"10.1016\/0006-8993(92)90672-V"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00479-7"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90094-X"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(99)00010-6"},{"issue":"4","key":"14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1254\/jjp.69.357","volume":"69","author":"MATSUDA T","year":"1995","ISSN":"https:\/\/id.crossref.org\/issn\/0021-5198","issn-type":"print"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0060171"},{"issue":"2","key":"16","first-page":"815","volume":"259","year":"1991","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Ago Y, Nakamura S, Uda M, Kajii Y, Abe M, Baba A, et al. Attenuation by the 5-HT<sub>1A<\/sub> receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice. Neuropharmacology. 2006;51:914&ndash;922.","DOI":"10.1016\/j.neuropharm.2006.06.001"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Ago Y, Nakamura S, Hayashi A, Itoh S, Baba A, Matsuda T. Effects of osemozotan, ritanserin and azasetron on cocaine-induced behavioral sensitization in mice. Pharmacol Biochem Behav. 2006;85:198&ndash;205.","DOI":"10.1016\/j.pbb.2006.07.036"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Ago Y, Nakamura S, Kajita N, Uda M, Hashimoto H, Baba A, et al. Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice. Synapse. 2007;61:757&ndash;763.","DOI":"10.1002\/syn.20421"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(99)00666-9"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01079-2"},{"key":"22","unstructured":"22 Tanaka T, Ishigooka J, Watanabe S, Nagata E, Miura S. Partial inhibition of reverse tolerance by a high dose of ritanserin or low dose of haloperidol in methamphetamine-sensitized rat. Jpn J Psychopharmcol. 1998;18:1&ndash;7."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Auclair A, Drouin C, Cotecchia S, Glowinski J, Tassin JP. 5-HT<sub>2A<\/sub> and &alpha;1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioral sensitization to opiates and psychostimulants. Eur J Neurosci. 2004;20:3073&ndash;3084.","DOI":"10.1111\/j.1460-9568.2004.03805.x"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.04137.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Ago Y, Koyama Y, Baba A, Matsuda T. Regulation by 5-HT<sub>1A<\/sub> receptors of the in vivo release of 5-HT and DA in mouse frontal cortex. Neuropharmacology. 2003;45:1050&ndash;1056.","DOI":"10.1016\/S0028-3908(03)00304-6"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 M&uuml;ller CP, Carey RJ, De Souza Silva MA, Jocham G, Huston JP. Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT<sub>1a<\/sub>-receptor antagonism blocks behavioral but potentiates serotonergic activation. Synapse. 2002;45:67&ndash;77.","DOI":"10.1002\/syn.10083"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 M&uuml;ller CP, De Souza Silva MA, DePalma G, Tomaz C, Carey RJ, Huston JP. The selective serotonin<sub>1A<\/sub>-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase. Behav Brain Res. 2002;134:337&ndash;346.","DOI":"10.1016\/S0166-4328(02)00042-6"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Przegali&ntilde;ski E, Filip M, Papla I, Siwanowicz J. Effect of serotonin (5-HT)<sub>1B<\/sub> receptor ligands on cocaine sensitization in rats. Behav Pharmacol. 2001;12:109&ndash;116.","DOI":"10.1097\/00008877-200104000-00004"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Davidson C, Lazarus C, Xiong X, Lee TH, Ellinwood EH. 5-HT<sub>2<\/sub> receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization. Eur J Pharmacol. 2002;453:255&ndash;263.","DOI":"10.1016\/S0014-2999(02)02390-7"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Filip M, Bubar MJ, Cunningham KA. Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT<sub>2<\/sub> receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther. 2004;310:1246&ndash;1254.","DOI":"10.1124\/jpet.104.068841"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 King GR, Xiong Z, Ellinwood EH Jr. Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT<sub>3<\/sub> receptor antagonist, and cocaine. Psychopharmacology. 1997;130:159&ndash;165.","DOI":"10.1007\/s002130050224"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 King GR, Xiong Z, Ellinwood EH Jr. Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT<sub>3<\/sub> receptor antagonist, administered during withdrawal from intermittent and continuous cocaine. Psychopharmacology. 1998;135:263&ndash;269.","DOI":"10.1007\/s002130050508"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00926-7"},{"issue":"2","key":"34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0022-3565(24)35331-5","volume":"292","author":"DE LA GARZA R II","year":"2000","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Szumlinski KK, Frys KA, Kalivas PW. Dissociable roles for the dorsal and median raphe in the facilitatory effect of 5-HT<sub>1A<\/sub> receptor stimulation upon cocaine-induced locomotion and sensitization. Neuropsychopharmacology. 2004;29:1675&ndash;1687.","DOI":"10.1038\/sj.npp.1300473"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(96)00472-8"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(00)00030-7"},{"issue":"2","key":"38","first-page":"486","volume":"263","year":"1992","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Sipes TA, Geyer MA. 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacology. 1995;117:41&ndash;48.","DOI":"10.1007\/BF02245096"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Narita M, Akai H, Nagumo Y, Sunagawa N, Hasebe K, Nagase H, et al. Implication of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in rats. Neuroscience. 2004;127:941&ndash;948.","DOI":"10.1016\/j.neuroscience.2004.06.017"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Hamamura T, Akiyama K, Akimoto K, Kashihara K, Okumura K, Ujike H, et al. Co-administration of either a selective D<sub>1<\/sub> or D<sub>2<\/sub> dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Brain Res. 1991;546:40&ndash;46.","DOI":"10.1016\/0006-8993(91)91156-U"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Shuto T, Kuroiwa M, Hamamura M, Yabuuchi K, Shimazoe T, Watanabe S, et al. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D<sub>1<\/sub> receptor agonist. Neuropharmacology. 2006;50:991&ndash;997.","DOI":"10.1016\/j.neuropharm.2006.01.009"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)00938-M"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Paulson PE, Robinson TE. Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse. 1995;19:56&ndash;65.","DOI":"10.1002\/syn.890190108"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0600839103"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Bortolozzi A, Amarg&oacute;s-Bosch M, Adell A, D&iacute;az-Mataix L, Serrats J, Pons S, et al. In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT<sub>2A<\/sub> receptors: Effect of antipsychotic drugs. Eur J Neurosci. 2003;18:1235&ndash;1246.","DOI":"10.1046\/j.1460-9568.2003.02829.x"},{"issue":"24","key":"47","doi-asserted-by":"crossref","first-page":"9856","DOI":"10.1523\/JNEUROSCI.21-24-09856.2001","volume":"21","author":"MARTIN-RUIZ R","year":"2001","ISSN":"https:\/\/id.crossref.org\/issn\/0270-6474","issn-type":"print"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T05:04:05Z","timestamp":1737867845000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/106\/1\/106_FM0070121\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.fm0070121","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}